Months 1 to 2: Improved sleep quality, faster recovery, subtle shifts in energy
This underscores the importance of viewing obesity as a chronic condition requiring long-term management rather than a short-term intervention
While medications like Semaglutide target only the GLP-1 receptor and Tirzepatide activates both GIP and GLP-1 receptors, Retatrutide adds glucagon receptor activation to create a more comprehensive metabolic intervention
Prokinetic agents such as metoclopramide or domperidone, which accelerate gastric emptying, may counteract some of the therapeutic effects of semaglutide on satiety and weight loss
These formulations are known as GLP-1 compound medications
They are affected by your cerebral, spinal, and peripheral components